跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
DESVENLAFAXINE-WGR XR desvenlafaxine 50 mg extended release tablet blister pack
Approved
STANDARD
DESVENLAFAXINE-WGR XR desvenlafaxine 50 mg extended release tablet blister pack
GM Pharma International Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
a8708a62de69aa0c
Company
GM Pharma International Pty Ltd
Type
Standard
Approval Details
Approval Id
a8708a62de69aa0c
Product Name
DESVENLAFAXINE-WGR XR desvenlafaxine 50 mg extended release tablet blister pack
Artg Id
439473
Artg Name
DESVENLAFAXINE-WGR XR desvenlafaxine 50 mg extended release tablet blister pack
Sponsor
GM Pharma International Pty Ltd
Company Detail Path
/organization/gm-pharma-international-pty-ltd
Artg Date
2024-05-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/840be5991cc8d733ae31dbbc89362725.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/4f565b1035a591a05af19e01ff380328.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
a8708a62de69aa0c
Type
Standard
Back to TGA Approvals
DESVENLAFAXINE-WGR XR desvenlafaxine 50 mg extended release tablet blister pack - TGA Drug Approval Details
